Vaxxinity Shares Rise After First Patient Dosed in Parkinson’s Study
By Sam Boughedda Investing.com — Vaxxinity Inc (NASDAQ:) inventory gained over 14.9% Wednesday after it mentioned the primary Parkinson's illness affected ...
Tag: Parkinsons
Pharma Two B reports positive Phase III Parkinson’s drug trial
Israeli drug improvement firm Pharma Two B Ltd. has reported constructive Section III outcomes from a trial on a remedy ...